Molly Henderson - Nov 1, 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
CFO and CBO
Signature
/s/ Larry Miller, Attorney-in-Fact for Molly Henderson
Stock symbol
PHAT
Transactions as of
Nov 1, 2023
Transactions value $
-$110,871
Form type
4
Date filed
11/3/2023, 04:55 PM
Previous filing
Jul 21, 2023
Next filing
Nov 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $0 +22.5K +23.64% $0.00 118K Nov 1, 2023 Direct F1
transaction PHAT Common Stock Sale -$6.33K -811 -0.69% $7.80 117K Nov 1, 2023 Direct F2
transaction PHAT Common Stock Sale -$105K -11.7K -9.99% $8.95 105K Nov 1, 2023 Direct F2
holding PHAT Common Stock 1.13K Nov 1, 2023 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned with respect to a performance stock unit award granted on January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.
F2 Represents shares sold to satisfy tax withholding obligations upon the settlement of performance stock units.